Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Cancer|May 10, 2018
Phase 2 trial of neoadjuvant chemotherapy and transoral endoscopic surgery with risk-adapted adjuvant therapy for squamous cell carcinoma of the head and neckJared M Weiss, Juneko E Grilley-Olson, Allison Mary Deal, et al.
JCO Precision Oncology|February 1, 2022
Tissue/Site-Agnostic Study of Ribociclib for Tumors With Cyclin D-CDK4/6 Pathway Genomic Alterations: A Phase II, Open-Label, Single-Arm Basket StudyJulio Peguero, Davendra P S Sohal, Bert H O'Neil, et al.
Journal of Clinical Pathology|August 19, 2025
Utility of the Singapore recurrence nomogram in a US cohort with a higher proportion of borderline and malignant phyllodes tumoursEllery H Reason, Samantha M Thomas, Jennifer K Plichta, et al.
JAMA Otolaryngology-- Head & Neck Surgery|May 6, 2016
Comparison of Patient- and Practitioner-Reported Toxic Effects Associated With Chemoradiotherapy for Head and Neck CancerAaron D Falchook, Rebecca Green, Mary E Knowles, et al.
Advances in Radiation Oncology|July 26, 2017
Use of mobile device technology to continuously collect patient-reported symptoms during radiation therapy for head and neck cancer: A prospective feasibility studyAaron D Falchook, Gregg Tracton, Lori Stravers, et al.
Cancer|March 27, 2018
Mature results of a prospective study of deintensified chemoradiotherapy for low-risk human papillomavirus-associated oropharyngeal squamous cell carcinomaBhishamjit S Chera, Robert J Amdur, Joel E Tepper, et al.
The Lancet. Oncology|July 29, 2019
Palbociclib and cetuximab in platinum-resistant and in cetuximab-resistant human papillomavirus-unrelated head and neck cancer: a multicentre, multigroup, phase 2 trialDouglas Adkins, Jessica Ley, Prakash Neupane, et al.
JCO Precision Oncology|July 17, 2018
Exceptional Chemotherapy Response in Metastatic Colorectal Cancer Associated With Hyper-Indel-Hypermutated Cancer Genome and Comutation of <i>POLD1</i> and <i>MLH1</i>Manish R Sharma, James T Auman, Nirali M Patel, et al.
Annals of Surgical Oncology|July 23, 2025
Circulating Tumor DNA (ctDNA) is Reliably Detected in Patients with Metastatic Malignant Phyllodes Tumors, a Feasibility StudyEllery H Reason, Michael D Aiduk, Amanda L Nash, et al.
Cancer Medicine|May 2, 2021
The addition of chemotherapy to adjuvant radiation is associated with inferior survival outcomes in intermediate-risk HPV-negative HNSCCJason Tasoulas, Nicholas R Lenze, Douglas Farquhar, et al.
Pageof 5